Batten disease: Evaluation of CLN3 mutations on protein localization and function

Human Molecular Genetics

Volumn 9, Issue 5, 2000, Pages 735-744

  Haskell, Ronald E ^a   Carr, Carrie J ^b   Pearce, David A ^b   Bennett, Michael J ^c   Davidson, Beverly L ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; SYNAPTOPHYSIN;

ARTICLE; ASSAY; CONTROLLED STUDY; DISEASE SEVERITY; GENE FUNCTION; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; NERVE CELL CULTURE; NEURONAL CEROID LIPOFUSCINOSIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0034701293     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.5.735     Document Type: Article

References (28)

1. The International Batten Disease Consortium (1995) Isolation of a novel gene underlying Batten disease, CLN3. Cell, 82, 949-957.
2. Taschner, P.E., de Vos, N. and Breuning, M.H. (1997) Cross-species homology of the CLN3 gene. Neuropediatrics, 28, 18-20.
3. Järvelä, I., Sainio, M., Rantamäki, T., Olkkonen, V.M., Carpén, O., Peltonen, L. and Jalanko, A. (1998) Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease, Hum. Mol. Genet., 7, 85-90.
4. Croopnick, J.B., Choi, H.C. and Mueller, D.M. (1998) The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in the juvenile form of Batten disease. Biochem. Biophys. Res. Commun., 250, 335-341.
5. Pearce, D.A., Ferea, T., Nosel, S.A., Das, B. and Sherman, F. (1999) Action of Btnlp, the yeast ortholog of the human Batten disease gene. Nature Genet., 22, 55-58.
6. Pearce, D.A. and Sherman, F. (1998) A yeast model for the study of Batten disease. Proc. Natl Acad. Sci. USA, 95, 6915-6918.
7. Munroe, P.B., Mitchison, H.M., O'Rawe, A.M., Anderson, J.W., Boustany, R.-M., Lerner, T.J., Taschner, P.E.M., de Vos, N., Breuning, M.H., Gardiner, R.M. and Mole, S.E. (1997) Spectrum of mutations in the Batten disease gene, CLN3. Am. J. Hum. Genet., 61, 310-316.
8. Wisniewski, K.E., Rapin, I. and Heaney-Kieras, J. (1988) Clinico-pathological variability in the childhood neuronal ceroid-lipofuscinoses and new observations on glycoprotein abnormalities. Am. J. Med. Genet., 5(suppl.), 27-46.
9. 2-terminal sequence. J. Biol. Chem., 264, 5736-5740.
10. Zhong, N., Wisniewski, K.E., Kaczmarski, A.L., Ju, W., Xu, W.M., Kaczmarski, W., Brooks, S.S. and Brown, W.T. (1998) Molecular screening of Batten disease: identification of a missense mutation (E295K) in the CLN3 gene. Hum. Genet., 102, 57-62.
11. Järvelä, I., Lehtovirta, M., Tikkanen, R., Kyttala, A. and Jalanko, A. (1999) Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL). Hum. Mol. Genet., 8, 1091-1098.
12. Haskell, R.E., Derksen, T.A. and Davidson, B.L. (1999) Intracellular trafficking of the JNCL protein CLN3. Mol. Genet. Metab., 66, 253-260.
13. Pullarkat, R.K. and Morris, G.N. (1997) Farnesylation of Batten disease CLN3 protein. Neuropediatrics, 28, 42-44.
14. Kaczmarski, W., Wisniewski, K.E., Golabek, A., Kaczmarski, A., Kida, E. and Michalewski, M. (1999) Studies of membrane association of CLN3 protein. Mol. Genet. Metab., 66, 261-264.
15. Margraf, L.R., Boriack, R.L., Routheut, A.A.J., Cuppen, I., Alhilali, L., Bennett, C.J. and Bennett, M.J. (1999) Tissue expression and subcellular localization of CLN3, the Batten disease protein. Mol. Genet. Metab., 66, 283-289.
16. Akasaki, K., Michihara, A., Mibuka, K., Fujiwara, Y. and Tsuji, H. (1995) Biosynthetic transport of a major lysosomal membrane glycoprotein, lamp-1: convergence of biosynthetic and endocytic pathways occurs at three distinctive points. Exp. Cell Res., 220, 464-473.
17. Akasaki, K., Michihara, A., Fujiwara, Y., Mibuka, K. and Tsuji, H. (1996) Biosynthetic transport of a major lysosome-associated membrane glycoprotein 2, lamp-2: a significant fraction of newly synthethesized lamp-2 is delivered to lysosomes by way of early endosomes. J. Biochem. (Tokyo), 120, 1088-1094.
18. Pittman, R.N., Wang, S., DiBenedetto, A.J. and Mills, J.C. (1993) A system for characterizing cellular and molecular events in programmed neuronal cell death. J. Neurosci., 13, 3669-3680.
19. Jahn, R., Schiebler, W., Ouimet, C. and Greengard, P. (1985) A 38,000-dalton membrane protein (p38) present in synaptic vesicles. Proc. Natl Acad. Sci. USA, 82, 4137-4141.
20. Katz, M.L., Gao, C.-L., Prabhakaram, M., Shibuya, H., Liu, P.-C. and Johnson, G.S. (1997) Immunochemical localization of the Batten disease (CLN3) protein in the retina. Invest. Ophthalmol. Vis. Sci., 38, 2375-2386.
21. Janes, R.W., Munroe, P.B., Mitchison, H.M., Gardiner, R.M., Mole, S.E. and Wallace, B.A. (1996) A model for Batten disease protein CLN3: functional implications from homology and mutations. FEBS Lett., 399, 75-77.
22. Kremmidiotis, G., Lensink, I.L., Bilton, R.L., Woollatt, E., Chataway, T.K., Sutherland, G.R. and Callen, D.F. (1999) The Batten disease gene product (CLN3p) is a Golgi integral membrane protein. Hum. Mol. Genet., 8, 523-531.
23. Puranam, K.L., Guo, W.-X., Qian, W.-H., Nikbakht, K. and Boustany, R.-M. (1999) CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide. Mol. Genet. Metab., 66, 294-308.
24. Regnier-Vigouroux, A., Tooze, S.A. and Huttner, W.B. (1991) Newly synthesized synaptophysin is transported to synaptic-like microvesicles via constitutive secretory vesicles and the plasma membrane. EMBO J., 10, 3589-3601.
25. Leube, R.E. (1995) The topogenic fate of the polytopic transmembrane proteins, synaptophysin and connexin, is determined by their membrane-spanning domains. J. Cell Sci., 108, 883-894.
26. Philippart, M., Messa, C. and Chugani, H.T. (1994) Spielmeyer-Vogt (Batten, Speilmeyer-Sjogren) disease. Distinctive patterns of cerebral glucose utilization. Brain, 117, 1085-1092.
27. Ito, H., Fukuda, Y., Murata, K. and Kimura, A. (1983) Transformation of intact yeast cells treated with alkali cations. J. Bacteriol., 153, 163-168.
28. Sherman, F. (1991) Getting started with yeast. Methods Enzymol., 194, 3-21.